We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer, BioNTech Unveil Positive Preliminary Data From German Vaccine Trial
Pfizer, BioNTech Unveil Positive Preliminary Data From German Vaccine Trial
Preliminary data from a German phase 1/2 trial showed that Pfizer’s and BioNTech’s mRNA-based coronavirus vaccine candidate is safe and generated immune responses in participants, the companies announced Monday.